Study of Tacrolimus Treatment on Refractory Recurrent Spontaneous Abortion (RSA) in Patients with Elevated Serum IL-33/ST2 Levels:A Randomized Controlled Trial
Latest Information Update: 17 Mar 2023
At a glance
- Drugs Tacrolimus (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
Most Recent Events
- 17 Mar 2023 New trial record
- 13 Mar 2023 Results assessing pregnancy outcomes of Tacrolimus in patients with refractory recurrent spontaneous abortion and immune bias disorders published in the European Journal of Clinical Pharmacology.